Startups
Caldan Therapeutics
Develops small molecule medicines targeting free fatty acid receptors for metabolic and inflammatory diseases. Its research includes FFA4 agonists for non-alcoholic steatohepatitis and approaches to type 2 diabetes, based on work at the Universities of Glasgow and Southern Denmark.
Founded 2015